1
|
Castro-Sayat M, Colaianni-Alfonso N, Vetrugno L, Olaizola G, Benay C, Herrera F, Saá Y, Montiel G, Haedo S, Previgliano I, Toledo A, Siroti C. Lung ultrasound score predicts outcomes in patients with acute respiratory failure secondary to COVID-19 treated with non-invasive respiratory support: a prospective cohort study. Ultrasound J 2024; 16:20. [PMID: 38457009 PMCID: PMC10923765 DOI: 10.1186/s13089-024-00365-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2023] [Accepted: 02/18/2024] [Indexed: 03/09/2024] Open
Abstract
BACKGROUND Lung ultrasound has demonstrated its usefulness in several respiratory diseases management. One derived score, the Lung Ultrasound (LUS) score, is considered a good outcome predictor in patients with Acute Respiratory Failure (ARF). Nevertheless, it has not been tested in patients undergoing non-invasive respiratory support (NIRS). Taking this into account, the aim of this study is to evaluate LUS score as a predictor of 90-day mortality, ETI (Endotracheal intubation) and HFNC (High Flow Nasal Cannula) failure in patients with ARF due to COVID-19 admitted to a Respiratory Intermediate Care Unit (RICU) for NIRS management. RESULTS One hundred one patients were admitted to the RICU during the study period. Among these 76% were males and the median age was 55 (45-64) years. Initial ARF management started with HFNC, the next step was the use of Continuous Positive Airway Pressure (CPAP) devices and the last intervention was ETI and Intensive Care Unit (ICU) admission. Of the total study population, CPAP was required in 40%, ETI in 26%, while 15% died. By means of a ROC analysis, a LUS ≥ 25 points was identified as the cut-off point for mortality(AUC 0.81, OR 1.40, 95% CI 1.14 to 1.71; p < 0.001), ETI (AUC 0.83, OR 1.43, 95% CI 1.20 to 1.70; p < 0.001) and HFNC failure (AUC 0.75, OR 1.25, 95% CI 1.12 to 1.41; p < 0.001). Kaplan-Meier survival curves also identified LUS ≥ 25 as a predictor of 90-days mortality (HR 4.16, 95% CI 1.27-13.6) and 30 days ETI as well. CONCLUSION In our study, a ≥ 25 point cut-off of the Lung Ultrasound Score was identified as a good outcome prediction factor for 90-days mortality, ETI and HFNC failure in a COVID-19 ARF patients cohort treated in a RICU. Considering that LUS score is easy to calculate, a multicenter study to confirm our findings should be performed.
Collapse
Affiliation(s)
- Mauro Castro-Sayat
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Nicolás Colaianni-Alfonso
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina.
| | - Luigi Vetrugno
- Department of Medical, Oral and Biotechnological Sciences, University of G. d' Annunzio, Chieti-Pescara, Italy
| | - Gustavo Olaizola
- Healthcare Unit Dr. Cesar Milstein, Buenos Aires, Argentina
- Rehabilitation and Respiratory Care Section, Italian Hospital of Buenos Aires, Buenos Aires, Argentina
| | - Cristian Benay
- Police Medical Complex Churruca-Visca, Buenos Aires, Argentina
- Bernardino Rivadavia Hospital, Buenos Aires, Argentina
| | - Federico Herrera
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Yasmine Saá
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Guillermo Montiel
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Santiago Haedo
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Ignacio Previgliano
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Ada Toledo
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
| | - Catalina Siroti
- Respiratory Intermediate Care Unit, Juan A. Fernandez Hospital, Av. Cerviño 3356, Buenos Aires, C1425 CABA, Argentina
- Dr. Antonio A Cetrángolo Hospital, Buenos Aires, Argentina
| |
Collapse
|
2
|
Colaianni-Alfonso N, Montiel G, Castro-Sayat M, Siroti C, Laura Vega M, Toledo A, Haedo S, Previgliano I, Mazzinari G, Miguel Alonso-Íñigo J. Combined Noninvasive Respiratory Support Therapies to Treat COVID-19. Respir Care 2021; 66:1831-1839. [PMID: 34290078 PMCID: PMC9993781 DOI: 10.4187/respcare.09162] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND The roles of high-flow nasal cannula (HFNC) and CPAP in coronavirus disease 2019 (COVID-19) are controversial. The objective of the study was to evaluate the impact of the application of a noninvasive respiratory support algorithm on clinical outcomes in subjects with COVID-19 and with acute respiratory failure. METHODS We performed a single-center prospective observational study of subjects with respiratory failure from COVID-19 managed with HFNC and with CPAP plus HFNC (combined therapy). The main outcome was the intubation rate, which defined failure of therapy. We also analyzed the role of the ROX index ([[Formula: see text]/[Formula: see text]]/breathing frequency) to predict the need for intubation. RESULTS From June to December 2020, 113 subjects with COVID-19 respiratory failure were admitted to our respiratory intermediate care unit. HFNC was applied in 65 subjects (57.52%) and combined therapy in 48 subjects (42.47%). A total of 83 subjects (73.45%) were successfully treated with noninvasive respiratory support. The intubation rate was 26.54%, and the overall mortality rate was 14.15%. The mortality rate in subjects who were intubated was 55.2%. An ROX index of 6.28 at 12 h predicted noninvasive respiratory support failure, with 97.6% sensitivity and 51.8% specificity. CONCLUSIONS Data from our cohort managed in a respiratory intermediate care unit showed that combined noninvasive respiratory support was feasible, with favorable outcomes. Further prospective studies are required.
Collapse
Affiliation(s)
- Nicolas Colaianni-Alfonso
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology.
| | - Guillermo Montiel
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Mauro Castro-Sayat
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Catalina Siroti
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Maria Laura Vega
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Ada Toledo
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Santiago Haedo
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Ignacio Previgliano
- Respiratory Intermediate Care Unit, Hospital Juan A. Fernández, Ciudad Autónoma de Buenos Aires, Argentina. Department of Pneumology
| | - Guido Mazzinari
- Hospital Universitario y Politécnico la Fe, Valencia, Spain. Research Group in Perioperative Medicine, Department of Anesthesiology
| | - José Miguel Alonso-Íñigo
- Hospital Universitario y Politécnico la Fe, Valencia, Spain. Research Group in Perioperative Medicine, Department of Anesthesiology
| |
Collapse
|